RNVU1-25

Across TCGA pan-cancer cohorts, RNVU1-25 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RNVU1-25 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RNVU1-25 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNVU1-25 expression acts as an unfavorable survival marker, although some lineages such as BLCA and PAAD show a favorable association.

KICH, STAD, and ACC are the cancer types where RNVU1-25 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.553	0.897	<.001	105	view →
STAD	DFS	Tertile	II,III,IV	0.507	0.716	.002	56	view →
ACC	OS	Tertile	III,IV	0.425	0.862	<.001	50	view →
THCA	OS	Quartile	II,III,IV	0.595	0.978	.001	47	view →
MESO	OS	Tertile	II,III,IV	0.176	0.617	<.001	45	view →
SKCM	DFS	Tertile	IV	0.091	0.518	.004	38	view →
LUAD	OS	Quartile	III,IV	0.297	0.590	.004	38	view →
READ	DFS	Tertile	IV	0.300	0.699	.009	27	view →
LAML	DFS	Quartile	All	0.196	0.437	.003	26	view →
LGG	DFS	Median	All	0.780	0.876	<.001	25	view →
DLBC	DFS	Tertile	III,IV	0.070	0.855	.008	18	view →
BLCA	OS	Quartile	IV	0.806	0.534	.007	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RNVU1-25–KICH (OS)

Open the KICH breakdown →